THE MEDICAL NEWS

Findings indicate that higher minimum wages are linked to reduced maternal hypertensive disorders, emphasizing the impact of economic policy on health outcomes.

Sapio Sciences, the science-aware™ AI lab informatics platform, today announced that the Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute’s ambitious lab transformation program.

Sapio Sciences, the science-aware™ AI lab informatics platform, today announced the availability of trusted, third-party scientific applications and platforms now integrated directly into Sapio ELaiN, its third-generation AI lab notebook.

Recreational physical activity may be associated with breast tissue composition and biomarkers of stress in adolescent girls, according to a new study from Columbia University Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center (HICCC).

In the largest Medicare Advantage fraud settlement to date, Kaiser Permanente has agreed to pay $556 million to settle Justice Department allegations that it billed the government for medical conditions patients didn't have.

Formulatrix, a leader in laboratory automation solutions, and Spear Bio, an innovator in ultrasensitive protein biomarker detection, today announced their ongoing partnership to automate and optimize the SPEAR UltraDetect™ assay platform using the F.A.S.T.™ (Flow Axial Seal Tip) Liquid Handler.

INTEGRA Biosciences is inviting labs to leave manual pipetting behind and take their first steps into effortless automation with a new Lab Evolution competition for 2026.

LI-COR announced today that its Carbon Node is the recipient of the "Internet of Environment Solution of the Year" award in the 10th annual IoT Breakthrough Awards program conducted by IoT Breakthrough.

A new blood marker reflects the extent of brain injury after an ischemic stroke and can predict patient outcomes months to years later.

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.

Bio-engineered skin grafts can play an important role in the treatment of burn victims. Researchers at the University of Zurich have been working on new approaches for such grafts for over 15 years.